PER 4.00% 7.2¢ percheron therapeutics limited

Ann: Positive outcomes in DMD combination therapy animal study, page-74

  1. 69 Posts.
    lightbulb Created with Sketch. 51
    The company needs a communication / marketing plan shake up - there are several areas that aren't well explained but I want us to shout out the answers of the following:

    - why is ANP unique to other drugs/companies in the DMD / MS / Limb-Girdle / Long Covid space?
    - why is ATL1102 unique?
    - where is the updated easy to read / visual calendar of expected events?
    - do we have the right stock broker looking after us? When was the last time they explained the company to their investors? When is the last time they purchased a share?

    Also, anyone able to access the website? Seems to be down?

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.003(4.00%)
Mkt cap ! $65.81M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $16.52K 226.7K

Buyers (Bids)

No. Vol. Price($)
2 123420 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 90481 2
View Market Depth
Last trade - 10.49am 29/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.